|
JPH0718000B2
(ja)
|
1985-05-15 |
1995-03-01 |
日本真空技術株式会社 |
合成樹脂被膜の形成方法
|
|
US4767627A
(en)
|
1985-05-29 |
1988-08-30 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4915952A
(en)
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
|
US4786503A
(en)
|
1987-04-06 |
1988-11-22 |
Alza Corporation |
Dosage form comprising parallel lamine
|
|
US5002772A
(en)
|
1988-05-31 |
1991-03-26 |
Pfizer Inc. |
Gastric retention system for controlled drug release
|
|
CA1340821C
(en)
|
1988-10-06 |
1999-11-16 |
Nobuyuki Fukazawa |
Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
|
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
EP0595894B1
(en)
|
1991-07-19 |
1995-12-20 |
UNIROYAL CHEMICAL COMPANY, Inc. |
Seed film compositions
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US5643909A
(en)
|
1993-04-19 |
1997-07-01 |
Syntex (U.S.A.) Inc. |
10,11-Methanodibenzosuberane derivatives
|
|
JPH0718000A
(ja)
*
|
1993-06-18 |
1995-01-20 |
Takeda Chem Ind Ltd |
新規ペプチド
|
|
US5451409A
(en)
|
1993-11-22 |
1995-09-19 |
Rencher; William F. |
Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
|
|
AU4151996A
(en)
|
1994-11-08 |
1996-05-31 |
Avicena Group, Inc. |
Use of creatine or creatine analogs for the treatment of diseases of the nervous system
|
|
US5945125A
(en)
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
|
MY113429A
(en)
|
1995-02-28 |
2002-02-28 |
Univ Temple |
Controlled release tablet containing swellable polyethylene oxide
|
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
AU721190B2
(en)
|
1995-10-11 |
2000-06-29 |
Avicena Group, Inc. |
Use of creatine analogues for the treatment of disorders of glucose metabolism
|
|
US5783212A
(en)
|
1996-02-02 |
1998-07-21 |
Temple University--of the Commonwealth System of Higher Education |
Controlled release drug delivery system
|
|
IT1282650B1
(it)
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
|
US6008252A
(en)
|
1996-07-26 |
1999-12-28 |
Beale; Paxton K. |
Method for increasing muscle mass in a mammal
|
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
GB9710699D0
(en)
|
1997-05-24 |
1997-07-16 |
Danbiosyst Uk |
Gastro-retentive controlled release system
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
PT1003476E
(pt)
|
1997-08-11 |
2005-05-31 |
Alza Corp |
Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica
|
|
US6090411A
(en)
|
1998-03-09 |
2000-07-18 |
Temple University |
Monolithic tablet for controlled drug release
|
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
|
US6476006B2
(en)
|
2000-06-23 |
2002-11-05 |
Teva Pharmaceutical Industries, Ltd. |
Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
|
|
US20030008007A1
(en)
|
2001-04-23 |
2003-01-09 |
Jose Gutierrez-Rocca |
Release pharmaceutical construct for gastric retention
|
|
US20030013767A1
(en)
|
2001-07-13 |
2003-01-16 |
Samuel Bessman |
Method of treating weight loss using creatine
|
|
US20040219186A1
(en)
|
2001-08-16 |
2004-11-04 |
Ayres James W. |
Expandable gastric retention device
|
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
AU2002363998A1
(en)
|
2001-12-15 |
2003-06-30 |
Spherics, Inc. |
Bioadhesive drug delivery system with enhanced gastric retention
|
|
EP1478345A4
(en)
|
2002-01-03 |
2010-11-17 |
Glaxosmithkline Llc |
NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
|
|
DE10221344A1
(de)
|
2002-05-14 |
2003-12-04 |
Hannover Med Hochschule |
Transgene Ratte und ihre Verwendung im Tiermodell für die humane Chorea Huntington Erkrankung sowie Nukleinsäurekonstrukte, Vektoren und Zellen zu ihrer Erzeugung
|
|
MXPA04011325A
(es)
*
|
2002-05-16 |
2005-02-14 |
Bayer Cropscience Gmbh |
Derivados de piridina-carboxamida y su uso como plaguicidas.
|
|
BR0310100A
(pt)
|
2002-05-17 |
2007-04-27 |
Esperion Therapeutics Inc |
métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto
|
|
US20040102525A1
(en)
|
2002-05-22 |
2004-05-27 |
Kozachuk Walter E. |
Compositions and methods of treating neurological disease and providing neuroprotection
|
|
US20040126366A1
(en)
|
2002-06-04 |
2004-07-01 |
Rima Kaddurah-Daouk |
Methods of treating cognitive dysfunction by modulating brain energy metabolism
|
|
GB0214013D0
(en)
|
2002-06-18 |
2002-07-31 |
Euro Celtique Sa |
Pharmaceutical product
|
|
WO2004002445A2
(en)
|
2002-06-26 |
2004-01-08 |
Cadila Healthcare Limited |
Novel floating dosage form
|
|
US20040120983A1
(en)
|
2002-12-23 |
2004-06-24 |
Philip Connolly |
Nutritional supplement
|
|
JPWO2005108370A1
(ja)
|
2004-04-16 |
2008-03-21 |
味の素株式会社 |
ベンゼン化合物
|
|
US8106093B2
(en)
|
2004-07-02 |
2012-01-31 |
Baylor Research Institute |
Glycogen or polysaccharide storage disease treatment method
|
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
|
US20060045865A1
(en)
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
|
US20080103202A1
(en)
|
2004-11-08 |
2008-05-01 |
Chris Ferguson |
Method of preparing creatine ester salts and uses thereof.
|
|
US20070012105A1
(en)
|
2005-07-13 |
2007-01-18 |
Barnes-Jewish Hospital |
Method and apparatus for resistive characteristic assessment
|
|
US20070032750A1
(en)
|
2005-07-15 |
2007-02-08 |
Jeffrey Oster |
Muscle strength assessment system
|
|
US7683043B2
(en)
|
2006-06-06 |
2010-03-23 |
Xenoport, Inc. |
Creatine phosphate analog prodrugs, compositions and uses thereof
|
|
WO2007146085A2
(en)
|
2006-06-06 |
2007-12-21 |
Xenoport, Inc. |
Creatine phosphate prodrugs, compositions and uses thereof
|
|
US20070281995A1
(en)
|
2006-06-06 |
2007-12-06 |
Xenoport, Inc. |
Creatine analog prodrugs, compositions and uses thereof
|
|
AU2007332800A1
(en)
|
2006-12-07 |
2008-06-19 |
Avicena Group, Inc. |
Creatine compositions for skin treatment
|
|
US7319157B1
(en)
|
2007-02-20 |
2008-01-15 |
Multi Formulations Ltd. |
Creatine-fatty acids
|
|
WO2008101310A1
(en)
|
2007-02-20 |
2008-08-28 |
Multi Formulations Ltd. |
Creatine-fatty acids
|
|
WO2008101309A1
(en)
|
2007-02-20 |
2008-08-28 |
Multi Formulations Ltd. |
Creatine-fatty acids
|
|
US8426395B2
(en)
|
2008-05-30 |
2013-04-23 |
Northern Northern Innovations Holding Corp |
Preparations containing creatine and imino sugars
|
|
WO2010005692A2
(en)
|
2008-06-16 |
2010-01-14 |
E. I. Du Pont De Nemours And Company |
Insecticidal cyclic carbonyl amidines
|
|
WO2010074591A1
(ru)
|
2008-12-24 |
2010-07-01 |
Закрытое Акционерное Общество "Beptekc" |
Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
|
|
CA2785714C
(en)
|
2009-12-30 |
2016-01-26 |
Baylor Research Institute |
Anaplerotic therapy for alzheimer's disease and the aging brain
|
|
CN103079555A
(zh)
|
2010-06-14 |
2013-05-01 |
贝勒研究院 |
用于成人葡萄糖多聚体病（apbd）治疗的三庚酸甘油酯膳食
|
|
JP5702248B2
(ja)
*
|
2011-07-28 |
2015-04-15 |
三菱製紙株式会社 |
ナノファイバー、ナノファイバーの形成方法およびナノファイバー集合体の形成方法
|
|
HK1200459A1
(en)
|
2011-09-19 |
2015-08-07 |
Gencia Corporation |
Modified creatine compounds
|
|
US9233099B2
(en)
|
2012-01-11 |
2016-01-12 |
University Of Cincinnati |
Methods of treating cognitive dysfunction by modulating brain energy metabolism
|
|
AR091857A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
|
EP2692719B1
(en)
|
2012-07-30 |
2016-06-08 |
Commissariat à l'Énergie Atomique et aux Énergies Alternatives |
Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof
|
|
ITTO20121098A1
(it)
|
2012-12-18 |
2014-06-19 |
Univ Degli Studi Genova |
Procedimento per sintetizzare derivati della creatina
|
|
JP6689199B2
(ja)
*
|
2013-08-30 |
2020-04-28 |
モーメンティブ・パフォーマンス・マテリアルズ・インク |
アミノ酸を含む湿気硬化性化合物
|
|
US20160289175A1
(en)
*
|
2013-11-05 |
2016-10-06 |
Ultragenyx Pharmaceutical Inc. |
Creatine analogs and the use thereof
|
|
ITTO20131070A1
(it)
|
2013-12-24 |
2015-06-25 |
Univ Degli Studi Genova |
Applicazione terapeutica di un derivato di creatina
|
|
US9642825B2
(en)
|
2014-02-27 |
2017-05-09 |
4141 Holdings, Llc |
Bio-available N-acetyl creatine species and compositions thereof
|
|
EP3194370A4
(en)
|
2014-09-03 |
2018-01-24 |
Lumos Pharma, Inc. |
Synthesis of cyclocreatine and analogs thereof
|
|
US9617230B2
(en)
|
2014-12-22 |
2017-04-11 |
Farmington Pharma Development |
Creatine prodrugs, compositions and methods of use thereof
|
|
WO2016110822A1
(en)
*
|
2015-01-09 |
2016-07-14 |
Universita' Degli Studi Di Genova |
Carboxylic biacyl creatine derivative, uses and method of synthesis thereof
|
|
US11021501B2
(en)
|
2015-03-30 |
2021-06-01 |
Farmington Pharma Development |
Creatine phosphate analog prodrugs, compositions and methods of use thereof
|
|
KR102678696B1
(ko)
|
2017-12-01 |
2024-06-27 |
울트라제닉스 파마수티컬 인코포레이티드 |
크레아틴 전구약물, 조성물과 이의 사용 방법
|